Denali Therapeutics Inc (DNLI)
Other Income/Expenses (Net)
$31.35M
TTM · Period ending: · USD
DNLI Other Income/Expenses (Net)
Latest reported$31.35Mperiod ending
Latest reported$31.35Mperiod ending
DNLI TTM Other Income/Expenses (Net) ($781.00K → $31.35M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
DNLI other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 31,348,000 | |
| 39,204,000 | |
| 42,904,000 | |
| 49,147,000 | |
| 54,610,000 | |
| 61,333,000 | |
| 64,636,000 | |
| 62,604,000 | |
| 61,051,000 | |
| 56,384,000 | |
| 51,505,000 | |
| 45,036,000 | |
| 34,781,000 | |
| 24,530,000 | |
| 14,774,000 | |
| 9,399,000 | |
| 6,217,000 | |
| 4,694,000 | |
| 4,595,000 | |
| 4,940,000 | |
| 5,879,000 | |
| 7,351,000 | |
| 9,241,000 | |
| 11,419,000 | |
| 13,257,000 | |
| 14,772,000 | |
| 15,219,000 | |
| 14,222,000 | |
| 13,033,000 | |
| 11,578,000 | |
| 10,132,000 | |
| 7,974,000 | |
| 5,825,000 | |
| 3,601,000 | |
| 1,955,000 | |
| 1,814,000 | |
| 1,601,000 | |
| 1,186,000 | |
| 781,000 |